Raul R. Gainetdinov is the Director of the Institute of Translational Biomedicine, Saint Petersburg State University (SPBU), Russia. Prior to SPBU, Raul R. Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute of Technology in Genova, Italy (2008-2016) and an Associate Research Professor in the Department of Cell Biology, Duke University in North Carolina, USA (1996-2008). In 2013-2018, he was also Professor of the Skolkovo Institute of Science and Technology (Skoltech), Moscow. Before joining the Department of Cell Biology at Duke University as a postdoctoral researcher in 1996 and becoming Assistant Research Professor at Duke in 2000, he conducted research at the Institute of Pharmacology Russian Academy of Medical Sciences in Moscow (1988-1996). He received a Ph.D. degree in pharmacology in 1992 from the Russian Academy of Medical Sciences and M.D. degree in 1988 from the Second Moscow Medical Institute, Moscow, Russia. Since 2013, he is an elected Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR). As of January 2020, he has more than 240 publications in scientific journals (including Science, Nature, Cell, PNAS) and co-authored 13 patents. His papers were cited more than 23,000 times (H-index – 74, ISI Web of Science). In 2018 and 2019, Raul R. Gainetdinov was included in the list of Web of Science (WOS) Highly Cited Researcher (HCR) representing top 0.1% of scientists in the world (https://recognition.webofsciencegroup.com/awards/highly-cited/2019/).